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Summary: Plasma fibronectin is dimiriished in patients with shock and septicaemia, probably äs a result of a decreased
function of the reticuloendothelial system (RES) of liver, spieen and bone marrow. A loss of plasma fibronectin was
also observed after haemoperfusion of patients with severe poisoning. The deposition of fibronectin on the surface
of cultured mouse liver Kupffer cells and the possible role of fibronectin in RES function are discussed.
Verlust von Fibronectin im Plasma von Patienten mit Schock und Septicaemie
sowie nach Hämoperfusion von Patienten mit schweren Vergiftungen
Zusammenfassung: Fibronectin im Plasma ist vermindert bei Patienten mit Schock und Sepsis, vermutlich in Zusam-
menhang mit verminderter Funktion des retikuloendothelialen Systems (RES) von Leber, Milz und Knochenmark.
Ein Verlust von Fibronectin im Plasma wurde auch nach Hämoperfusion von Patienten mit schweren Vergiftungen
beobachtet. Es wird über die Verteilung von Fibronectin auf den Zelloberflächen kultivierter Kupffer-Zellen von
Mäuselebern und über die Bedeutung von Fibronectin für die RES-Funktion berichtet.
Introduction
The high molecular weight glycoprotein fibronectin
from plasma, ceU-surface arid intercellular connective
tissue matrix, has been shown to have varioüs functions,
e.g. in cell attachment and in connective tissue formation.
Fibronectin seems to be identical with the LETS factor
(large external transformation sensitive factor), cold-
insoluble globulin and anti-gelatin factor. Furthermore
fibronectin is closely related to or identical with a-op-
sonic glycoprotein. Fibronectin is an opsoiiin, for
example, it enhances endocytosis of bacterial toxins
(1—4), collagens, fibrinogen and cells. Depressed levels
of -opsönic glycoprotein have been fqund in plasma of
patients with shock and septicaemia (1,5), indicating
that fibronectin Supports the function of the reticulo-
endothelial System. Further evidence to support this
Suggestion is given elsewhere (1). In a previous con-.
tribution we repprted aii easily-handled immuno-test to
measure fibronectin in human plasma (6). Using this
laser nephelometry assay, we have estimated fibronectin
in the plasma of patients with septicaemia and/pr shock,
before and after haemoperfusion for the treatment of
severe poisoning.
. . . .2) Supported by Deutsche Forschungsgemeinschaft, Bonn-Bad
Godesbeig (SFB 104, A4).
Patients, Materials and Methods
Fibronectin was meäsured in 8 patients with cardiogenic shock,
in 12 patients with pancreatogenic shock and in 16 patients
with septicaemia. In five patients with septicaemia caused by
staphylococcal infection and in four patients with cardiogenic
shock, a föllpw-up study was performed; fibronectin was
meäsured and varioüs other laboratory and cardiopulmonary
tests were carried out. In four patients with severe poisoning
(2 X paraquat, 2 X bromocarbamide) fibronectin was deter-
mined before and after haemoperfusion.
Fibronectin in plasma was determined äs described in earlier
literature (6). Briefly, the final test consists of: 100 plasma,
dilution 1:10 in 0.15 mol/1 NaQ, 200 antiserum, dilution
1:5 (Behring-Werke); 1:10 (own preparation) in 0.15 moi/1
NaCl.
Fibronectin was purified and antibodies were raised in rabbits äs
described elsewhere (6). For the routine assay an antibody
against fibronectin (from Behring-Werke, Marburg/Lahn, FRG)
was used, which did not cross-react with fibrinogen. The com-
mon laboratory tests, including blood clotting tests and cardio-
pulmonary function tests, were carried out äs described (5).
Repeated haemoperfusion with coated charcoal (Gambro, He-
chingen, FRG) was done according to Yatzidis (7).
Results and Discussion
Fibronectin levels in plasma of patients with shock from
different causes or with septicaemia are markedly de-
pressed (fig. 1). In follow-up studies the survivors
showed an increase to normal concentrations, whereas
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Fig. 1. Fibronectin concentrations in the plasma of patients with
shock and septicaemia. n = normal healthy controls.
l = x±lS.
the non-survivors had depressed levels üntil their deaths
(fig. 2). Plasma fibronectin is also depressed after häemo-
perfusion (fig. 3). Depressed levels of -opsonic glyco-
protein, which may be identical with fibronectin have
been reported by Saba et äl. and by Blumenstock et al.
(2,8).
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Fig. 2. Follow-up observations in patients with shock and septic-
aemia.
o acute liver failure
o, ·, · septicaemia, caused by Staphylococcus infection
* septicaemia, bacterial infection not identified
·,
A
 non-survivors
The fact, that fibronectin is depressed in patients with
septicaemia provides further evidence that these pro-
teins may be identical or very closely related. Endo^
thelial cells (1), hepatocytes and macrophages (9) con-
tain and synthesize large amourits of fibronectin. Con-
ditions of phagocytosis of coated and labelled particles
in the blood flow mediated by fibronectin have been
published recently (reviews I.e. (2, 10)).
From studies with mouse Kupffer cells (9), and hepato-
cytes (l 1) it is concluded that these cells produce fibro-
nectin which is deposited äs a meshwork on the cell
surface; this site of deposition of fibronectin is presum-
ably related to its role in phagocytosis. We have observed
depression of fibronectin in plasma not only in cases of
septicaemia but also in patients with shock. This may be
due to the fact that under shock conditions the func-
tion of the reticüloendothelial System is also depressed.
This Supports the evidence that fibronectin may be an
indicator of the functional efficiency of the reticulo*
endothelial System.
In this cormeetiori, the observation that fibronectin
decreases after haemoperfusion of patients with various
types pf poisoning may be significant. It could be due to
adhesion öf fibronectin, like other plasma pröteins (7)
to the coated charcoal. Work is in progress, using im-
muno-fluorescence, to investigate whethef fibfonectin
is bpund to the coated charcoal after haemoperfusion.
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Fig. 3. Fibronectin concentrations in the plasma of patients
before and after several haemoperfusions.
B, o, A paraquat poisoning
, , , v bromocarbamide poisoning
Conclusions
Our results suppoft the hypöthesis that fibronectin may
play an important role in the function of the reticülo-
endothelial System. This may be the faet not önly in
patients with septicaemia but also in patients with
shock, äs a sign of depressed phagoey tosis of the reticulo-
endothelial System. This suppörts the evidence that it
might be necessary to substitute fibronectiri in patients
with depressed levels. Initial treatments with cryojpre-
cipitate (2) by Saba & Blumenstock demonstrate a
dramatically improved survival rate compared with non-
treated patients. Cryoprecipitate contains high concen-
trations of fibronectin.
These therapeutic measures should be contüiued with
highly purified fibronectin, and consideration should
also be given to the use of fibronectin infusions in
pafients undergoing haemopeifüsion.änd showing a
marked fall in fibronectin concentrations in the plasma.
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